| |
 |
 |
1.Huang SY, Wu CC, Hsieh MC, Rau KM, Chiang PH, Sung MT, Luo HL, Huang CC, Huang CH, Liu JM, Su HY. Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma. Oncology. 2020;98(3):146-153. doi: 10.1159/000504393. Epub 2019 Dec 3.
2.Chia-Che Wu, Kun-Ming Rau, Wei-Chieh Lee, Meng-Che Hsieh, Jia-Sin Liu, Yen-Yang Chen, and Harvey Yu-Li Su. Presence of Chronic Obstructive Pulmonary Disease (COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study. J Clin Med. 2019 Jul 12;8(7). pii: E1024. doi: 10.3390/jcm8071024.
3.Wu CC, Li SH, Lu HI, Lo CM, Wang YM, Chou SY, Chen YH. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis. PeerJ. 2018 Sep 19;6:e5655. doi: 10.7717/peerj.5655. eCollection 2018.
4.Chien TL, Rau KM, Chung WJ, Tai WC, Wang SH, Chiu YC, Wu KL, Chou YP, Wu CC, Chen YH, Chuah SK; Gastric Cancer Team. Trousseau` syndrome in a patient with advanced stage gastric cancer. World J Gastroenterol. 2015 Sep 14;21(34):10049-53. doi: 10.3748/wjg.v21.i34.10049.
5.Chia-Che Wu, Meng-Chih Lin, Jui-Long Wang, Kun-Ming Rau, Yen-Yang Chen, Cheng-Hua Huang. Pemetrexed as Third-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer (NSCLC): A Retrospective Analysis. 台灣癌症醫學雜誌；27卷4期 (2011 / 08 / 01)，P157 - 164
|
|
